City Different Investments Global Equity ETF (CDIG)
Live price chart, market sentiment, and community perspectives for City Different Investments Global Equity ETF (NASDAQ: CDIG).
Live price chart, market sentiment, and community perspectives for City Different Investments Global Equity ETF (NASDAQ: CDIG).
On our desk, we're looking at CDIG's sector tilts with extreme caution. While the headline portfolio P/E of roughly 14.5x looks optically cheap against the 17.8x category average, that discount is entirely function-driven by heavy cyclical exposures—roughly 20% in energy, 29% in consumer cyclical, and 10% in basic materials. If macro growth stalls, those cyclical weights are going to feel the pinch. Combined with a YTD price return sitting in the 91st percentile worst of the Global Large-Stock Blend category, the fundamental setup here is unfavorable for the next 6 to 12 months.
Reviewing the risk architecture for CDIG reveals critical data gaps that make institutional deployment difficult. Morningstar's 3-year, 5-year, and 10-year period tables completely miss fund-level drawdowns, capture ratios, and volatility measures due to its September 2025 inception. The single available metric—a 1-year beta of 1.04—shows market-like sensitivity, but a Sharpe ratio of -0.04 confirms that recent return-per-risk has been dismal. Morningstar rates both risk and return as 'Low' relative to the category, reinforcing the classic below-risk, below-return trap.
From a quantitative execution standpoint, trading CDIG requires strict limit-order discipline. With only about $47.8 million in assets under management and a daily dollar volume hovering around $42K, the fund's liquidity profile is exceptionally thin. Add an annual expense ratio of 0.75%—which sits well above standard active and passive global peers—alongside a wide 12 basis point bid-ask spread, and retail buyers face heavy friction on every single trade execution. It fails practically every quantitative hurdle we test for broad equity allocations.
Explore plasma cleansing, somatic organ swaps, and BCI.